Elevated XIAP expression alone does not confer chemoresistance
Authors:
Open Access
- 18 May 2010
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 102 (12) , 1717-1723
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 24 references indexed in Scilit:
- X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer modelCell Death & Differentiation, 2008
- Diagnosing and exploiting cancer's addiction to blocks in apoptosisNature Reviews Cancer, 2008
- Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer RecurrenceClinical Cancer Research, 2007
- NF-κB–independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugsBlood, 2006
- XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attackBlood, 2006
- Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyEMBO Reports, 2006
- Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cellsOncogene, 2006
- Targeting XIAP for the treatment of malignancyCell Death & Differentiation, 2005
- IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspasesThe EMBO Journal, 1998
- X-linked IAP is a direct inhibitor of cell-death proteasesNature, 1997